181 related articles for article (PubMed ID: 38508723)
1. Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry-based de novo sequencing.
Peng W; Giesbers KC; Šiborová M; Beugelink JW; Pronker MF; Schulte D; Hilkens J; Janssen BJ; Strijbis K; Snijder J
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38508723
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
3. Bovine Muc1 is a highly polymorphic gene encoding an extensively glycosylated mucin that binds bacteria.
Sando L; Pearson R; Gray C; Parker P; Hawken R; Thomson PC; Meadows JR; Kongsuwan K; Smith S; Tellam RL
J Dairy Sci; 2009 Oct; 92(10):5276-91. PubMed ID: 19762846
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
5. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
6. MUC1 splice variants in human ocular surface tissues: possible differences between dry eye patients and normal controls.
Imbert Y; Darling DS; Jumblatt MM; Foulks GN; Couzin EG; Steele PS; Young WW
Exp Eye Res; 2006 Sep; 83(3):493-501. PubMed ID: 16631167
[TBL] [Abstract][Full Text] [Related]
7. MUC1: a target molecule for cancer therapy.
Singh R; Bandyopadhyay D
Cancer Biol Ther; 2007 Apr; 6(4):481-6. PubMed ID: 18027437
[TBL] [Abstract][Full Text] [Related]
8. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S
Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750
[TBL] [Abstract][Full Text] [Related]
9. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
[TBL] [Abstract][Full Text] [Related]
10. The contribution of tandem repeat number to the O-glycosylation of mucins.
Silverman HS; Sutton-Smith M; McDermott K; Heal P; Leir SH; Morris HR; Hollingsworth MA; Dell A; Harris A
Glycobiology; 2003 Apr; 13(4):265-77. PubMed ID: 12626424
[TBL] [Abstract][Full Text] [Related]
11. Human corneal and conjunctival epithelia express MUC1 mucin.
Inatomi T; Spurr-Michaud S; Tisdale AS; Gipson IK
Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1818-27. PubMed ID: 7635656
[TBL] [Abstract][Full Text] [Related]
12. Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis.
Ciborowski P; Finn OJ
Clin Exp Metastasis; 2002; 19(4):339-45. PubMed ID: 12090474
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
[TBL] [Abstract][Full Text] [Related]
14. In vivo glycosylation of mucin tandem repeats.
Silverman HS; Parry S; Sutton-Smith M; Burdick MD; McDermott K; Reid CJ; Batra SK; Morris HR; Hollingsworth MA; Dell A; Harris A
Glycobiology; 2001 Jun; 11(6):459-71. PubMed ID: 11445551
[TBL] [Abstract][Full Text] [Related]
15. Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.
Kinlough CL; Poland PA; Gendler SJ; Mattila PE; Mo D; Weisz OA; Hughey RP
J Biol Chem; 2011 Nov; 286(45):39072-81. PubMed ID: 21937430
[TBL] [Abstract][Full Text] [Related]
16. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast.
Mommers EC; Leonhart AM; von Mensdorff-Pouilly S; Schol DJ; Hilgers J; Meijer CJ; Baak JP; van Diest PJ
Int J Cancer; 1999 Oct; 84(5):466-9. PubMed ID: 10502721
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
[TBL] [Abstract][Full Text] [Related]
19. Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines.
Poland PA; Kinlough CL; Rokaw MD; Magarian-Blander J; Finn OJ; Hughey RP
Glycoconj J; 1997 Jan; 14(1):89-96. PubMed ID: 9076518
[TBL] [Abstract][Full Text] [Related]
20. Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
Hong JC; Kim YS
Glycoconj J; 2000 Oct; 17(10):691-703. PubMed ID: 11425189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
